Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.
about
Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro.Shikonin inhibits myeloid differentiation protein-2 to prevent lipopolysaccharide-induced acute lung injury.Cancer cells induce interleukin-22 production from memory CD4+ T cells via interleukin-1 to promote tumor growth.Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease.Development of a Novel Backbone Cyclic Peptide Inhibitor of the Innate Immune TLR/IL1R Signaling Protein MyD88.
P2860
Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting of MyD88 Homodimeriz ...... -Associated Colorectal Cancer.
@en
type
label
Targeting of MyD88 Homodimeriz ...... -Associated Colorectal Cancer.
@en
prefLabel
Targeting of MyD88 Homodimeriz ...... -Associated Colorectal Cancer.
@en
P2093
P2860
P356
P1476
Targeting of MyD88 Homodimeriz ...... -Associated Colorectal Cancer.
@en
P2093
Feng-Chao Jiang
Jian-Hua Liu
Li-Min Zhang
Ming-Qiang Li
Shuai Xing
Wen-Tao He
P2860
P356
10.1093/JNCI/DJV364
P407
P577
2015-12-28T00:00:00Z